The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
F. Reichenberger, R. Voswinckel, M. Thamm, F. Lendeckel, R. Schulz, M. Kappert, J. Dämming, R. Morty, C. Tanislav, H. A. Ghofrani, W. Seeger, H. Tiede (Giessen, München-Gauting, Germany)
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Reichenberger, R. Voswinckel, M. Thamm, F. Lendeckel, R. Schulz, M. Kappert, J. Dämming, R. Morty, C. Tanislav, H. A. Ghofrani, W. Seeger, H. Tiede (Giessen, München-Gauting, Germany). The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3933
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: